4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-055948
EVP, Chief Development Officer bought 50,000 shares at $0.94 ($46,995)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Forbes William P EVP, Chief Development Officer | 2023-11-16 | Purchase | +50,000 | $0.94 | $46,995 | 54,000 | D |
| Open-market purchases · 50,000 sh · avg $0.94 · $46,995 | |||||||
Loading xslF345X05/doc4.xml…